
Kanchanjanga Medipharma Private Limited
Pharmaceutical company engaged in trading and manufacturing of medicines, established in 2012.
Pharmaceutical company engaged in trading and manufacturing of medicines, established in 2012.
Kanchanjanga Medipharma Private Limited (KMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 August 2012 and has a history of 12 years and seven months. Its registered office is in Darjiling, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nand Jalan, Tapan Saha, Alok Paul, and Four other members serve as directors at the Company.
Darjiling, West Bengal, India
+91-XXXXXXXXXX
-
U24233WB2012PTC184337
184337
Private Limited Indian Non-Government Company
02 Aug 2012
30 Sep 2024
31 Mar 2024
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Alok Paul ![]() | Director | 02-Aug-2012 | Current |
Nand Jalan ![]() | Director | 02-Aug-2012 | Current |
Tapan Saha ![]() | Director | 02-Aug-2012 | Current |
Pradip Paul ![]() | Director | 25-Jun-2013 | Current |
Dilip Saha ![]() | Director | 25-Jun-2013 | Current |
Uttam Saha ![]() | Director | 25-Jun-2013 | Current |
Kanchanjanga Medipharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.38% increase. The company also saw a slight improvement in profitability, with a 9.62% increase in profit. The company's net worth moved up by a moderate rise of 1.03%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Kanchanjanga Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Nand Jalan, Tapan Saha and 1 more are mutual person
Nand Jalan, Tapan Saha and 1 more are mutual person
There are no open charges registered against the company as per our records.
Kanchanjanga Medipharma has a workforce of 55 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kanchanjanga Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanchanjanga Medipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kanchanjanga Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Kanchanjanga Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.
Sujata Bhowal was appointed as a Director was appointed as a Director on 29 Mar 2024 & has been associated with this company since 11 months 6 days .
Pradip Kumar Paul was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 11 years 8 months .
Dilip Kumar Saha was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 11 years 8 months .
Uttam Saha was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 11 years 8 months .
Kanchanjanga Medipharma Private Limited was incorporated on 02 Aug 2012.
The authorized share capital of Kanchanjanga Medipharma Private Limited is ₹ 1.01 Cr and paid-up capital is ₹ 1.00 Cr.
Currently 7 directors are associated with Kanchanjanga Medipharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kanchanjanga Medipharma Private Limited is Majumder Medi Trade Kuchery Rd Opp. Hospital, India, Siliguri, West Bengal, 734001.
The corporate identification number (CIN) of Kanchanjanga Medipharma Private Limited is U24233WB2012PTC184337 and the company number is 184337 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Kanchanjanga Medipharma Private Limited has risen by 23.38%.
As Per 2022 financial reports, 55 employees are currently employed by Kanchanjanga Medipharma Private Limited.
The financial reports for the fiscal year 2022 indicates that The net worth of Kanchanjanga Medipharma Private Limited has experienced an upsurge of 1.03%.
The most recent Balance Sheet for Kanchanjanga Medipharma Private Limited was filed with the ROC on 31 Mar 2024.
MB